Following The Culture Trail
Amitabh Dube, country president of Novartis India, has travelled extensively, but it is his stay in Vietnam that he most fondly remembers, not just for its food, people and landscape but also for the footprints of Indian culture in the southeast Asian country
Chitra Nair - July 29, 2023
At Home With Art
Novartis India’s Ranjit Shahani’s enviable collection reflects his journey from a novice to an expert in contemporary art
Krishna Gopalan - August 19, 2017
Managing Growth 2017- Part 2
Will demonetisation hurt? Can the Budget spur a growth recovery? Here's what four CEOs predicted for the next fiscal
March 17, 2017
Making A Fresh Start
CEOs from diverse sectors on what's in store for 2017
March 17, 2017
Cash-rich picks in the current market
Looking for cash bargains? Here is a first cut list
Jitendra Kumar Gupta - August 26, 2015
Wind beneath his wings
India's most reticent billionaire is betting his money on the alternative energy space and here's why
Krishna Gopalan - May 05, 2015
Will Sun rise again?
Can Sun Pharma’s Dilip Shanghvi work his merger magic on Ranbaxy?
Kripa Mahalingam - June 15, 2015
Critical condition
Drug majors are shifting clinical trials out of India as lawmakers turn on the heat
Kripa Mahalingam - June 17, 2015
The other shoe drops
It took Reebok India five years to wake up to financial irregularities of nearly ₹900 crore. What happens now?
Krishna Gopalan - December 14, 2015